Erratum: Androgen therapy in women: For whom and when (Archives of Gynecology and Obstetrics (2013) 288 (731-737) DOI:10.1007/s00404-013-2969-7);Androgen therapy in women: For whom and when

Archives of Gynecology and Obstetrics

Volumn 288, Issue 4, 2013, Pages 731-737

  Pluchino, Nicola ^a   Carmignani, Arianna ^a   Cubeddu, Alessandra ^a   Santoro, Anna ^a   Cela, Vito ^a   Alcalà, Tania Errasti ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

DHEA S; Reproductive aging; Testosterone

Indexed keywords

ANDROGEN; PLACEBO; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE;

ANDROGEN DEFICIENCY; ANDROGEN THERAPY; ANOREXIA NERVOSA; ARTICLE; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; HUMAN; LOW DRUG DOSE; POSTMENOPAUSE; RISK FACTOR; SEXUAL DYSFUNCTION;

AGING; ANDROGENS; DEHYDROEPIANDROSTERONE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; POSTMENOPAUSE; PREMENOPAUSE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 84885373917     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-3051-1     Document Type: Erratum

References (45)

1. Davis SR, Panjari M, Stanczyk FZ (2011) DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 96:1642-1653
2. Davison SL, Bell R, Donath S, Montalto JG, Davis SR (2005) Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90:3847-3853
3. Labrie C, Bélanger A, Labrie F (1988) Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 123:1412-1417
4. Labrie F (2003) Extragonadal synthesis of sex steroids: intracrinology. Ann Endocrinol (Paris) 64:95-107
5. Judd HL, Judd GE, Lucas WE, Yen SS (1974) Endocrine function of the postmenopausal ovary concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 39:1020-1024
6. Rabinovici J, Rothman P, Monroe SE, Nerenberg C, Jaffe RB (1992) Endocrine effects and pharmacokinetic characteristics of a potent new GnRH antagonist (Ganirelix) with minimal histamine-releasing properties: studies in postmenopausal women. J Endocrinol Metab 75:1220-1225
7. Judd HL, Lucas WE, Yen SS (1974) Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol 118:793-798
8. Couzinet B, Meduri G, Lecce MG, Young J, Brailly S, Loosfelt H et al (2001) The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab 86:5060-5066
9. Liu CH, Laughlin GA, Fischer UG, Yen SS (1990) Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20 desmolase enzymatic activity. J Clin Endocrinol Metab 71:900-907
10. Couch RM, Muller J, Winter JS (1986) Regulation of the activities of 17-hydroxylase and 17,20-desmolase in the human adrenal cortex: kinetic analysis and inhibition by endogenous steroids. J Clin Endocrinol Metab 63:613-618
11. Mortola JF, Yen SS (1990) The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 71:696-704
12. Morales AJ, Nolan JJ, Nelson JC, Yen SS (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78:1360-1367
13. Luu-The V, Dufort I, Pelletier G, Labrie F (2001) Type 5 17 beta-hydroxysteroid dehydrogenase: its role in the formation of androgens in women. Mol Cell Endocrinol 171:77-82
14. Al-Azzawia F, Palacios S (2009) Hormonal changes during menopause. Maturitas 63:135-137
15. Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L et al (2002) Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 77:660-665
16. Shifren JL, Davis SR, Dennerstein L, Heiman JR, Lobo RA, Simon JA (2005) The role of testosterone therapy in postmenopausal women: position statement of the North American Menopause Society. Menopause 12:497-511
17. Wierman ME, Basson R, Davis SR, Khosla S, Miller KK, Rosner W et al (2006) Androgen therapy in women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91:3696-3710
18. Wylie K, Rees M, Hackett G, Anderson R, Bouloux PM, Cust M et al (2010) Androgens, health and sexuality in women and men. Review. Maturitas 67:275-289
19. Schwenkhagena A, Studdb J (2009) Role of testosterone in the treatment of hypoactive sexual desire disorder. Maturitas 63:152-159
20. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J et al (2000) Report of the International Consensus Development Conference on Female Sexual Dysfunction: definitions and classifications. J Urol 163:888-893
21. Braunstein GD (2006) Androgen insufficiency in women. Growth Horm IGF Res 16 (Suppl A): S109-17
22. Turna B, Apaydin E, Semerci B, Altay B, Civili N, Nazli O (2005) Women with low libido: correlation of decreased androgen levels with female sexual function index. Int J Impot Res 17:148-153
23. Guay A, Jacobson J, Munarriz R, Traish A, Talakoub L, Quirk F et al (2004) Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: part B. Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction. Int J Impot Res 16:121-129
24. Santoro N, Torrens J, Crawford S, Allsworth JE, Finkelstein JS, Gold EB, Korenman S et al (2005) Correlates of circulating androgens in mid-life women: the study of women's health across the nation. J Clin Endocrinol Metab 90:4836-4845
25. Basson R, Brotto LA, Petkau AJ, Labrie F (2010) Role of androgens in women's sexual dysfunction. Menopause 17:962-971
26. Davis SR, Davison SL, Donath S, Bell RJ (2005) Circulating androgen levels and self-reported sexual function in women. JAMA 294:91-96
27. Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M et al (2008) Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 359:2005-2017
28. Panay N, Al-Azzawi F, Bouchard C, Davis SR, Eden J, Lodhi I et al (2010) Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric 13:121-131
29. Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA et al (2005) Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 165:1582-1589
30. Goldstat R, Briganti E, Tran J et al (2003) Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause 10:390-398
31. Davis S, Papalia MA, Norman RJ, O'Neill S, Redelman M, Williamson M et al (2008) Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial. Ann Intern Med 148:569-577
32. Braunstein GD (2007) The Endocrine Society Clinical Practice Guideline and The North American Menopause Society position statement on androgen therapy in women: another one of Yogi's forks. J Clin Endocrinol Metab 92:4091-4093
33. Lobo RA (2001) Androgens in postmenopausal women: production, possible role, and replacement options. Obstet Gynecol Surv 56:361-376
34. Moutos D, Smith S, Zacur H (1995) The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial. Contraception 52:105-109
35. Carlstrom K, Karlsson R, Von Schoultz B (2002) Diurnal rhythm and effects of oral contraceptives on serum dehydroepiandrosterone sulfate (DHEAS) are related to alterations in serum albumin rather than to changes in adrenocortical steroid secretion. Scand J Clin Lab Invest 62:361-368
36. Miller KK, Lawson EA, Mathur V, Wexler TL, Meenaghan E, Misra M et al (2007) Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab 92:1334-1339
37. Lawson EA, Misra M, Meenaghan E, Rosenblum L, Donoho DA, Herzog D (2009) Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa. J Clin Endocrinol Metab 94:1367-1371
38. Miller KK, Grieco KA, Klibanski A (2005) Testosterone administration in women with anorexia nervosa. J Clin Endocrinol Metab 90:1428-1433
39. Panjari M, Davis SR (2010) DHEA for postmenopausal women: a review of the evidence. Maturitas 66:172-179
40. Labrie F, Luu-The V, Bélanger A, Lin SX, Simard J, Pelletier G et al (2005) Is dehydroepiandrosterone a hormone? J Endocrinol 187:169-196
41. Davis SR, Shah SM, McKenzie DP, Kulkarni J, Davison SL, Bell RJ (2008) Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women. J Clin Endocrinol Metab 93:801-808
42. Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M et al (2006) Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Gynecol Endocrinol 22:627-635
43. Simoncini T, Mannella P, Fornari L, Varone G, Caruso A, Genazzani AR (2003) Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 144:3449-3455
44. Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL et al (2009) Serum steroid levels during 12-weeks intravaginal dehydroepiandrosterone administration. Menopause 16:897-906
45. Pluchino N, Ninni F, Stomati M, Freschi L, Casarosa E, Valentino V et al (2008) One-year therapy with 10 mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu. Maturitas 20:293-303